Tanja Spanic (@TanjaSpanic)

New update with longer follow up from POSITIVE trial for young women with HR+ breast cancer 💕
I’m proud to be part of this trial from the very beginning 💕⬇️

Annals of Oncology @Annals_Oncology Jun 2

🆕 Results from the POSITIVE trial with longer term follow-up are now out in @Annals_Oncology

Temporary interruption of endocrine therapy to attempt pregnancy is safe and does not increase the risk of #breastcancer events @AnnPartridgeMD
doi.org/10.1016/j.anno…

View quoted post on X

Tanja Spanic @TanjaSpanic May 31

Patients are the ultimate stakeholders in cancer research. Key takeaway from @stage4kelly at #ASCO26: every clinical trial should include patient-reported outcomes and quality of life measures. The best clinical trials are designed with patients and include PROs

@OncoAlert

Tanja Spanic @TanjaSpanic May 31

Important results from Optima trail 💕⬇️

Elisabetta Bonzano MD, PhD Verified account @to_be_elizabeth May 30

📌First results from the OPTIMA phase Ill randomized non-inferiority trial of test-directed chemotherapy in patients with high clinical risk ER-positive HER2-negative early breast cancer.
✨Robert C. Stein at #ASCO26
🔗 OPTIMA demonstrates that the 50-gene Prosigna test identifies a group of about 2/3 of patients with ER-positive HER2-negative early breast cancer who do not have a meaningful chance of benefit from adjuvant chemotherapy.
@OncoAlert #OncoAlertAF #BreastCancer

View quoted post on X

Tanja Spanic @TanjaSpanic May 29

Finally here in person 😉#ASCO26

Tanja Spanic @TanjaSpanic Apr 10

#aya awareness week
#diagnosedat26

Allison Rosen, MS @ARosen380 Apr 6

This week is Adolescent & Young Adult Cancer Awareness Week.

This week focuses on ~89,000 people 15–39 diagnosed w/ cancer annually. This week highlights the unique challenges faced: lower survival improvements, fertility, financial stress, & disruption to education & careers!

View quoted post on X

Tanja Spanic

Latest posts 5